Remove Medical Remove Pharmaceutical Remove Therapy
article thumbnail

Ligand Pharmaceuticals Launches Pelthos to Accelerate Commercialization of Zelsuvmi for Molluscum; Appoints New CEO

The Dermatology Digest

Ligand Pharmaceuticals is launching Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and has appointed Scott Plesha as Chief Executive Officer to accelerate the commercialization of berdazimer topical gel, 10.3% (Zelsuvmi) for the treatment of molluscum contagiosum. Zelsuvmi received a Novel Drug designation from the U.S.

article thumbnail

Oh, The Places Dermatology Will Go in 2024!

The Dermatology Digest

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Warts and All: Verrica and Torii Team Up to Fund Global Phase 3 Trial of YCANTH for Common Warts

The Dermatology Digest

Verrica Pharmaceuticals Inc. has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. alone and no FDA approved therapies, common warts represent one of the largest unmet needs in all of dermatology. With a prevalence of approximately 22 million patients in the U.S.

article thumbnail

LEVEL UP Period 2 Data: AD Patients Who Switched From Dupilumab to Upadacitinib Hit Higher Treatment Targets

The Dermatology Digest

These findings indicate that upadacitinib may address an unmet medical need in patients with moderate-to-severe AD who do not achieve an adequate response while taking dupilumab,” conclude researchers who were led by Christopher Bunick, MD, PhD, an Associate Professor of Dermatology at Yale University in New Haven, CT.

article thumbnail

GLP-1 and Appetite Control: How it Works and Why it’s Effective

West Lake Dermatology

The increasing popularity of weight loss medications like semaglutide and tirzepatide highlights the effectiveness of GLP-1 receptor agonists in helping individuals manage their weight. In clinical trials, medications like semaglutide have shown substantial results. However, as with any medication, there are potential side effects.

Medical 36
article thumbnail

Benefits of the Trigger Point Massage

Hollywood Institute

Not only is this condition curable, but you aren’t restricted to opioids or other pharmaceutical treatments. Curious if , massage therapy is the right solution for your chronic pain? What is Trigger Point Therapy? What are the Benefits of Trigger Point Therapy?

Therapy 52
article thumbnail

Chronic and Mysterious Symptoms May Be Autoimmunity and can take years to diagnose

Aesthetics Advisor

Most medical schools still only teach how to identify late-stage autoimmune disease, not how to identify autoimmunity in its early stages and nor how to affect its progression through dietary, nutritional, pharmaceutical, or lifestyle applications. Every supplement and every therapy is a shot in the dark.